Dr. Moldt has significant experience in corporate strategy, company operations, and drug development.  He was most recently CEO of Curalogic A/S, a company he cofounded in 2004 and subsequently took public.  Before Curalogic A/S, he was Chief Operating Officer of 7TM Pharma A/S, a company which he cofounded in 2000.  Prior to 2000, Dr. Moldt spent 11 years with NeuroSearch A/S, where he was responsible for all aspects of pre-clinical and clinical drug development.  Dr. Moldt holds a PhD in medicinal chemistry from the Royal Danish School of Pharmacy, and has been a post-doc with Yale University’s Department of Organic Chemistry.